ADVANCED ACCELERATOR APPLICATIONS
Advanced Accelerator Applications (AAA), is a European Pharmaceutical Group founded in 2002 by Italian academics as a spin-off of the “European Organization for Nuclear Research” (CERN), Geneva, Switzerland), to develop innovative diagnostic and therapeutic products. AAA’s main focus is in the field of Molecular Imaging and targeted, individualized therapy for the management of patients with serious conditions (Personalized Medicine). AAA is a European leader in the production and co... mmercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology. AAA also produces a broad range of SPECT products. AAA currently has 17 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 300 employees in 11 countries (France, Italy, UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, United States and Canada).
ADVANCED ACCELERATOR APPLICATIONS
Industry:
Health Diagnostics Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Saint-genis-pouilly, Rhone-Alpes, France
Country:
France
Website Url:
http://www.adacap.com
Total Employee:
251+
Status:
Active
Contact:
33 4 50 99 30 70
Email Addresses:
[email protected]
Total Funding:
144.29 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content IPv6 Amazon Virginia Region Microsoft Microsoft Azure New Relic Shutterstock Apple Whitelist YouTube IFrame Upload
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Advanced Accelerator Applications
T. Rowe Price
T. Rowe Price investment in Venture Round - Advanced Accelerator Applications
Adage Capital Management
Adage Capital Management investment in Venture Round - Advanced Accelerator Applications
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Advanced Accelerator Applications
Tamburi Investment Partners
Tamburi Investment Partners investment in Venture Round - Advanced Accelerator Applications
Seventure Partners
Seventure Partners investment in Private Equity Round - Advanced Accelerator Applications
Naxicap Partners
Naxicap Partners investment in Private Equity Round - Advanced Accelerator Applications
Official Site Inspections
http://www.adacap.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.15 K
- Host name: 172.64.150.155
- IP address: 172.64.150.155
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Advanced Accelerator Applications"
Advanced Accelerator Applications - Wikipedia
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases. In late October 2017, Reuters announced that Novartis would acquire the company for $3.9 billion…See details»
Advanced Accelerator Applications (Italy) S.r.l. - bioPmed
The patent has been developed at CERN (The European Organization for Nuclear research) by Physics Nobel Laureate Carlo Rubbia and his team (which included AAA founder Stefano …See details»
History - adacap.com
Pursue medical applications for certain research conducted during his tenure at the European Organization for Nuclear Research, or CERN, with Nobel laureate Carlo Rubbia. 2002 2002 …See details»
Advanced Accelerator Applications | LinkedIn
Advanced Accelerator Applications | 37,655 followers on LinkedIn. We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – …See details»
Advanced Accelerator Applications - Crunchbase
Organization. Advanced Accelerator Applications . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AAA is an …See details»
S. BUONO | CEO | Advanced Accelerator Applications SA, Saint …
Stefano Buono is an accomplished physicist and alumnus of The European Organization for Nuclear Research (CERN). For the past 15 years, Mr. Buono has served as Chief Executive …See details»
Advanced Accelerator Applications - Datanyze
Adacap Inc. Primary Industries. Manufacturing Pharmaceuticals. Contact Information. Headquarters. 20 Rue Diesel, Saint-Genis-Pouilly, Auvergne-Rhone-Alpes, 01630, France …See details»
Advanced Accelerator Applications Information
Adacap.com; 2 845271XXXX; 845729XXXX; Thierry Barsalou Deputy Head IT and Senior Global Head Service Delivery at Advanced Accelerator Applications Geneva, GE, CH View. 1 …See details»
Career Search - Advanced Accelerator Applications
At Advanced Accelerator Applications, a Novartis company, our mission is to transform lives through radioligand therapy in nuclear medicine to fight several leading types of cancer.See details»
Advanced Accelerator Applications - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Advanced Accelerator Applications. Use the PitchBook Platform to explore the full profile.See details»
Cartography of the Geneva Health Hub - Health field concerned ...
Advanced Accelerator Applications is reimagining nuclear medicine and cancer care. Its mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and …See details»
Advanced Accelerator Applications - ZoomInfo
Jan 11, 2024 Advanced Accelerator Applications contact info: Phone number: +33 450993070 Website: www.adacap.com What does Advanced Accelerator Applications do? Founded in …See details»
Novartis announces the planned acquisition of Advanced …
Basel, October 30, 2017 - Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to …See details»
Radiopharmaceutical cancer treatment Lutathera® now available …
Oct 8, 2020 Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs; Lutathera directly targets tumours by binding to …See details»
Advanced Accelerator Applications Receives FDA Approval for
Basel, January 26, 2018 - Novartis AG (NYSE: NVS) today announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug …See details»
Advanced Accelerator Applications Usa (JNM4NBNHFE66)
Advanced Accelerator Applications Usa (UEI JNM4NBNHFE66, CAGE 3PTH3) based in Millburn NJ federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Loading...
Loading... ... Loading...See details»
AdaCap: Adaptive Capacity control for Feed-Forward Neural …
May 9, 2022 AdaCap optimizes the capacity of FFNN so it can capture the high-level abstract representations underlying the problem at hand without memorizing the training dataset. …See details»
Caps – Fire Grooved | Tyco Fire
ADACAP available only in Europe; Full back stop behind the groove to ensure proper coupling engagement and rigidity; Available painted or galvanized finish; 300 psi pressure rated; End-of …See details»